Helixomer, Inc.
Hillsborough, NC
- UEI
- K5RKRPEAQQ33
- CAGE
- 969D4
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1428 Chanterelle Ln, Hillsborough, NC 27278, USA
- Website
- helixomer.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of an RNA-based anticoagulant and antidote for precise on/off coagulation control during cardiovascular… | National Heart Lung and Blood Institute (NIH) | $3,100,481 |
Quick answers
Is Helixomer, Inc. registered in SAM.gov?
Yes. Helixomer, Inc.'s SAM.gov registration is active through December 5, 2026.
What is Helixomer, Inc.'s most recent federal award?
Helixomer, Inc.'s most recent federal grant award is Development of an RNA-based anticoagulant and antidote for precise on/off coagulation control during cardiovascular… (R44HL167436), from National Heart Lung and Blood Institute (NIH), on September 1, 2023.
On GovTribe
See Helixomer, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors